Dong-A Socio Holdings Co.,Ltd
Financials
Valuation Metrics
Dong-A Socio Holdings Co.,Ltd's Market Cap is ₩6356B. At end of 2025 it was ₩7166B. Ranked #415 of 2,419 in KR market (top 17%), #266 of 781 on KOSPI (top 34%), #45 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 19%) by Market Cap.
Investment Metrics(as of 2026-10-07)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 635.55B KRW | KR#415/2,419 Sec#45/231 |
| Revenue | 1.52T KRW | KR#315/2,419 Sec#11/231 |
| Net Income | 84.87B KRW | KR#279/2,419 Sec#17/231 |
| Total Assets | 2.21T KRW | KR#288/2,419 Sec#11/231 |
| Net Assets | 1.21T KRW | KR#253/2,419 Sec#12/231 |
| Employees | 82 | KR#1,793/2,419 Sec#148/231 |
| Value | ||
| P/E | 7.49x | KR#611/2,419 Sec#27/231 |
| P/B | 0.53x | KR#838/2,419 Sec#39/231 |
| P/S | 0.42x | KR#793/2,419 Sec#27/231 |
| EV/EBITDA | 9.51x | KR#581/2,419 Sec#25/231 |
| FCF Yield | 28.03% | KR#204/2,419 Sec#3/231 |
| Profitability | ||
| ROE | 7.03% | KR#879/2,419 Sec#61/231 |
| ROA | 3.84% | KR#908/2,419 Sec#74/231 |
| Op. Margin | 7.07% | KR#718/2,419 Sec#57/231 |
| Revenue Growth | 10.06% | KR#894/2,419 Sec#87/231 |
| Earnings Growth | -4.53% | KR#854/2,419 Sec#53/231 |
| Financial Health | ||
| Debt Ratio | 82.93% | KR#1,388/2,419 Sec#160/231 |
| Total Debt | 569.88B KRW | KR#285/2,419 Sec#9/231 |
| FCF | 178.13B KRW | KR#125/2,419 Sec#3/231 |
| Cash | 183.91B KRW | KR#292/2,419 Sec#12/231 |
| Current Ratio | 0.82x | KR#1,924/2,419 Sec#187/231 |
| Net Debt/EBITDA | 3.60x | KR#942/2,419 Sec#71/231 |
| Dividend | ||
| Div. Yield | 1.74% | KR#928/2,419 Sec#49/231 |
| Div. Growth | 0.00% | KR—/2,419 Sec—/231 |
| Performance | ||
| 1Y Return | -13.60% | KR#1,118/2,419 Sec#72/231 |
| 1M Return | 2.50% | KR#950/2,419 Sec#93/231 |
| From 52W High | -22.55% | KR#339/2,419 Sec#17/231 |
| 1Y MDD | -36.44% | KR#452/2,419 Sec#32/231 |
| Trading | ||
| Volume | 4,715 shares | KR#2,158/2,419 Sec#213/231 |
| Trading Value | 444.2M KRW | KR#1,041/2,419 Sec#122/231 |
| Foreign Own. | 17.08% | KR#273/2,419 Sec#15/231 |
| Per Share | ||
| EPS | 12,607 KRW | KR#87/2,419 Sec#7/231 |
| BPS | 179,308 KRW | KR#81/2,419 Sec#4/231 |
Company Info
Dong-A Socio Holdings, established in 1949 and listed on the KOSPI in 1970, transitioned to a holding company structure in 2014. It operates seven reporting divisions including manufacturing and sales of OTC drugs and quasi-drugs, biosimilar and CMO production, logistics, and manufacturing of packaging containers and bottled water, with subsidiaries Dong-A ST and ST Pharm. This holding company structure supports independent decision-making and autonomous management for its subsidiaries, strengthening business competitiveness and securing growth potential. Dong-A Socio Holdings is headquartered in Dongdaemun-gu, Seoul.